Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis

Carcinogenesis

Volumn 17, Issue 8, 1996, Pages 1623-1632

  James, Neil H ^a   Roberts, Ruth A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; ETOPOSIDE; HYDROXYUREA; METHYLCLOFENAPATE; NAFENOPIN; PEROXISOME PROLIFERATOR; PHENOBARBITAL; PIRINIXIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TUMOR PROMOTER;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA SYNTHESIS; GUINEA PIG; HAMSTER; LIVER CARCINOGENESIS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

EID: 0029776373     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.8.1623     Document Type: Article

References (51)

1. Ashby, J. and Tennant, R. (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mutat. Res., 257, 229-306.
2. Green, S. (1991) The search for the molecular mechanisms of non-genotoxic carcinogenesis. Mutat. Res., 248, 371-374.
3. Reddy, J.K., Azarnoff, D.L. and Hignite, C.E. (1980) Hypolipidaemic hepatic peroxisome proliferate form a novel class of chemical carcinogens. Nature, 283, 397-398.
4. Moody, D.E., Reddy, J.K., Lake, B.G., Popp, J.A. and Reese, D.H. (1991) Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium. Fund. Appl. Toxicol., 6, 233-248.
5. Ashby, J., Brady, A., Elcombe, C.R., Elliot, B.M., Ishmael, J., Odum, J., Tugwood, J.D., Kettle, S. and Purchase, I.F.H. (1994) Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol., 13, S1-S117.
6. Reddy, J.K., Rao, M.S., Azarnoff, D.L. and Sell, S. (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator Wy-14 643 in rat and mouse liver. Cancer Res., 39, 152-160.
7. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators. Evaluation of the risk of hypolidaemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol., 12, 1-58.
8. Styles, J.A., Kelly, M., Pritchard, N.R. and Elcombe, C.R. (1988) A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatcyte. Carcinogenesis, 9, 1647-1655.
9. Barrass, N.C., Price, R.J., Lake, B.G. and Orton, T.C. (1993) Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis, 14, 1451-1456.
10. Barber, E.D., Astill, B.D., Moran, E.J., Schneider, B.F., Gray, T.J.B., Lake, B.G. and Evans, J.G. (1987) Peroxisome induction studies on seven phthalate esters. Toxicol. Indust. Health, 3, 130.
11. Elcombe, C.R. (1985) Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch. Toxicol., 6-7.
12. Bentley, P., Calder, I., Elcombe, C., Grasso, P., Wiegand, H.G. and Stringer, D.A. (1992) Hepatic peroxisome proliferation. ECETOC Monograph No. 17.
13. Bentley, P., Calder, I., Elcombe, E., Grasso, P., Stringer, D. and Wiegand, H.J. (1993) Hepatic peroxisome proliferation in rodents and its significance to humans. Food Chem. Toxicol., 31, 857-907.
14. Williams, G. (1996) Peroxisome proliferation in the livers of non-human primates and humans. Annals N.Y. Acad. Sci., in press.
15. Lake, B.G., Evans, J.G., Gray, T.J.B., Korosi, S.A. and North, C.J. (1989) Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig and marmoset. Toxicol. Appl. Pharmacol., 99, 148-160.
16. Price, R.J., Evans, J.G. and Lake, B.G. (1992) Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster. Food Chem. Toxicol., 30, 937-944.
17. Elcombe, C.R. and Mitchell, A. (1986) Peroxisome proliferation due to di(2-ethyl) phthalate: species differences and possible mechanisms. Environ. Health Perspect., 70, 211-219.
18. Hanefeld, M., Hemmer, C. and and Kadner, E. (1983) Relationship between morphological changes and lipid lowering action of p-chlorophenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis, 46, 239-246.
19. Cohen, S.M. and Ellwein, L.B. (1989) Cell proliferation in carcinogenesis. Science, 249, 1007-1011.
20. Ames, B.N. and Gold, L.S. (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science, 249, 970-971.
21. Schulte-Hermann, R. (1979) Adaptive liver growth induced by xenobiotic compounds: its nature and mechanism. Arch. Toxicol. Suppl., 2, 113-124.
22. Schulte-Hermann, R., Hoffann, V., Parzefall, W., Kallenbach, M., Gerhardt, A. and Schuppler, J. (1980) Adaptive responses of the liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth. Chem.-Biol. Interactions, 31, 287-300.
23. Bursch, B., Lauer, B., Timmerman-Trosiener, I., Barthel, G., Schuppler, J. and Schulte-Hermann, R. (1984) Controlled death (apoptosis) of normal and preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis, 5, 453-458.
24. Bursch, W., Taper, H.S., Lauer, B. and Schulte-Hermann, R. (1985) Quantitative and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch., 50, 153-166.
25. Bursch, W., Dusterberg, B. and Schulte-Hermann, R. (1986) Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch. Toxicol., 59, 221-227.
26. Oberhammer, F.A. and Roberts, R.A. (1994) Apoptosis: a widespread process involved in liver adaptation and carcinogenesis. In Arias, I.M., Boyer, J.L., Fausto, N., Jakoby, W.B., Schachter, D. and Shafritz, D.A. (eds), The Liver: Biology and Pathobiology, Raven Press, New York, pp. 1547-1556.
27. Alison, M.R. and Sarraf, C.E. (1995) Apoptosis: regulation and relevance to toxicology. Hum. Exp. Toxicol., 14, 234-247.
28. Bayly, A.C., Roberts, R.A. and Dive, C. (1995) Mechanisms of apoptosis. In (eds), Advances in Molecular and Cell Biology: Mechanisms of Cell Toxicity, in press.
29. Bayly, A.C., French, N.J., Dive, C. and Roberts, R.A. (1993) Non-genotoxic hepatocarcinogenesis in vitro: the Fao hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. J. Cell Sci., 104, 307-315.
30. Bayly, A.C., Roberts, R.A. and Dive, C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J. Cell Biol., 125, 197-203.
31. Roberts, R.A., Soames, A.R., Gill, J.H., James, N.H. and Wheeldon, E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different discrete hepatocyte populations. Carcinogenesis, 16, 1693-1698.
32. Gill, J.H., Molloy, C.M., Shoesmith, K., Bayly, A.C. and Roberts, R.A. (1995) The rodent non-genotoxic hepatocarcinogen nafenopin and EGF alter the mitosis/apoptosis balance promoting hepatoma clonal growth. Cell Death Different., 2, 211-217.
33. Seglen, P.O. (1973) Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp. Cell Res., 82, 391-398.
34. James, N.H., Molloy, C.A., Soames, A.R., French, N.J. and Roberts, R.A. (1992) An in vitro model of rodent hepatocarcinogenesis. Exp. Cell Res., 203, 407-419.
35. James, N.H. and Roberts, R.A. (1995) Species differences in the clonal expansion of hepatocytes in response to the co-action of epidermal growth factor and nafenopin, a rodent hepatocarcinogenic peroxisome proliferator. Fund. Appl. Toxicol., 26, 143-149.
36. Edwards, A.M. and Lucas, C.M. (1985) Phenobarbital and some other live tumor promoters stimulate DNA synthesis in cultured rat hepatocytes. Biochem. Biophys. Res. Commun., 131, 103-108.
37. Wyatt, I., Gyte, A., Foster, J.R., Williams, S.M. and Elcombe, C.R. (1993) Differences in the response of rat and guinea pig liver and thyroid to hepatic enzyme inducers (abstract). Hum. Exp. Toxicol., 12, 561.
38. Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645-650.
39. Watanabe, T., Horie, S., Yamada, J., Isaji, M., Nishigaki, T., Naito, J. and Suga, T. (1989) Species differences in the effects of bezafibrate, a hypolipidaemic agent, on hepatic peroxisome associated enzymes. Biochem. Pharmacol., 38, 430-437.
40. Peraino, C., Fry, R.J.M. and Staffeldt, E. (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-aminofluorene. Cancer Res., 31, 1506-1512.
41. Periano, C., Fry, R.J.M., Staffeldt, E. and Christopher, J.P. (1975) Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydrantoin amd dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumourigenesis in the rat. Cancer Res., 35, 2884-2890.
42. Berman, J.S., Hiley, C.R. and Wilson, A.C. (1983) Comparison of the effects of the hypolipidaemic agents ICI53072 and clofibrate with those of phenobarbitone on live size, blood flow and DNA content in the rat. Br. J. Pharmacol., 78, 533-541.
43. Pines, J. (1994) Arresting developments in cell cycle control. TIBS, 19, 143-145.
44. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M. and Koff, A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Gene Dev., 8, 9-22.
45. Hannon, G.J. and Beach, D. (1994) p15INK4B is a potential effector of TGFb-induced cell cycle arrest. Nature, 371, 257-261.
46. Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G. and Wahli, W. (1992) Control of the β-oxidation pathway by a novel family of nuclear hormone receptors. Cell, 68, 879-887.
47. Schmidt, A., Endo, N., Rutledge, S.J., Vogel, R., Shinar, D. and Rodan, D.A. (1992) Identification of a new member of the steroid hormone receptor superfamily activated by a peroxisome proliferator and fatty acids, Mol. Endocrinol., 6, 1634-1641.
48. Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K. and Evans, R.M. (1994) Differential expression and activation of a family of murine peroxisome proliferator activated receptors. Proc. Natl Acad. Sci. USA, 91, 7355-7359.
49. Lee, S.S.-T., Pineau, T., Drago, J., Lee, E.J., Owens, J.O., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H. and Gonzalez, F.J. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleitrophic effects of peroxisome proliferators. Mol. Cell. Biol., 15, 3012-3022.
50. Sher, T., Yi, H.F., McBride, W. and Gonzalez, F.J. (1993) cDNA cloning, chromosomal mapping and functional characterisation of the human peroxisome proliferator-activated receptor. Biochemistry, 32, 5598-5604.
51. Mitchell, A.M., Bridges, J.W. and Elcombe, C.R. (1984) Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch. Toxicol., 55, 239-246.